查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1847196

印度牙科移植骨替代物市場：市場規模、佔有率和趨勢分析（2025-2031）

Dental Bone Graft Substitutes Market Size, Share & Trends Analysis | India | 2025-2031 | Includes: Barrier Membranes, Antimicrobial Periodontal Treatment, and 2 more
出版日期: | 出版商: iData Research Inc. | 英文 80 Pages | 商品交期: 最快1-2個工作天內

價格
如有價格方面的疑問請按下「詢問」鍵來信查詢

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年印度牙科移植骨替代物(DBGS) 和其他生醫材料市場規模超過 5,600 萬美元，預計到 2031 年將達到近 1.51 億美元。

本報告涵蓋牙科移植骨替代物、牙科屏障膜、局部抗菌牙周治療以及牙科軟組織傷口護理—統稱為牙科生醫材料市場。該報告對銷售額、平均售價 (ASP)、市場規模、成長率和企業市場占有率進行了全面分析，並提供了截至 2031 年的預測數據和截至 2021 年的實際數據。

印度市場是全球成長最快的市場之一，這主要得益於人工植牙普及率的提高、臨床醫生培訓的廣泛開展以及消費者對再生醫學治療意識的增強。牙科旅遊的蓬勃發展和對私人診所投資的增加進一步推動了對先進生醫材料的需求，尤其是合成和異種移植的DBGS產品以及牙科屏障膜。

市場概覽

受人口和經濟發展趨勢的推動，印度牙科生醫材料市場正處於強勁擴張階段。中階的壯大、人們審美意識的提升以及植入治療的普及，都促進了再生牙科產品的市場應用。

歷史上，由於成本優勢和供應便利，印度生物活性骨移植（DBGS）市場一直以合成材料為主。然而，近年來，異質骨移植市場穩步成長，憑藉更完善的滅菌技術、更佳的臨床療效以及來自知名國際製造商的品牌推廣，贏得了臨床醫生的信賴。

印度正在發生的一項重要變化是牙科屏障膜的接受度和應用率不斷提高。雖然這些產品過去不如牙科生物膜材料普及，但現在它們已被公認為引導骨再生（GBR）和引導組織再生（GTR）手術的重要組成部分。特別是可吸收膠原蛋白膜，在教育推廣和企業主導的研討會的推動下，其應用率正在迅速提高。

印度的市場結構由蓋斯特利希（Geistlich）、士卓曼集團（Straumann Group）和哈爾瑪（Halma）等全球領導企業，以及本土經銷商和區域性參與企業組成。印度的牙科基礎設施和採購管道較為分散，因此建立本地夥伴關係和分銷管道至關重要。

總體而言，植入數量的增加、患者意識的提高以及國內外供應商的大力行銷正在推動成長，使印度成為亞太地區最有前途的牙科生醫材料市場之一。

市場促進因素

人工植牙治療的發展

齒槽骨移植是植入治療中必不可少的環節，它支持植入植入前後的骨修復。隨著印度私人牙科領域植入的快速普及，齒槽骨移植材料的需求也持續成長。

雖然並非所有植入都​​需要植骨，但相當一部分病例，尤其是在上顎和下顎後牙區，透過植骨可以確保長期穩定性。植入植入與植骨之間的這種結構性聯繫，決定了隨著植入手術的成長，對骨移植的需求也會增加。

提高消費者意識

消費者對人工植牙和再生手術的認知度正在顯著提高，患者透過數位管道和植入及生醫材料製造商贊助的教育宣傳活動，對他們的治療選擇有了更深入的了解。

不斷擴大的知識庫提高了臨床接受度和消費者信心，促進了 DBGS 和屏障膜產品的穩定應用。

捆綁銷售和投資組合擴展

領先的牙科公司正利用產品捆綁銷售策略，交叉銷售再生生物材料、膜和植入系統。包括蓋斯特利希（Geistlich）、士卓曼（Straumann）和哈爾瑪（Halma）在內的許多全球公司，在植入產品之外還提供再生材料，鼓勵臨床醫生從單一供應商處採購配套產品。

此類夥伴關係簡化了牙科診所的物流，並提高了操作流程的一致性。例如，Geistlich 的 Bio-Gide® 薄膜通常與 Bio-Oss®異質骨移植搭配使用，而 Straumann 則將其 Bone Ceramic® 材料作為植入再生方案的一部分進行推廣。

此次將植入和生醫材料產品組合整合起來，將增強銷售綜效，並提高整體市場滲透率。

私人醫療保健和牙科旅遊的發展

印度私人醫療保健行業的擴張和蓬勃發展的牙科旅遊業正推動對先進牙科技術的投資不斷增加。服務於國際患者和國內富裕患者的診所擴大採用高階牙科生物材料和膜材料，以確保可預測的美學效果。

具有競爭力的價格和日益成長的國際聲譽使印度成為植入治療的首選目的地，進一步推動了對再生材料的需求。

市場限制

改善口腔衛生

政府和非政府組織主導的口腔衛生宣傳活動正在提高印度各地民眾對預防牙科的認知，這從公共衛生角度來看是有益的，但從長遠來看，可能會抑制對修復和再生手術的需求。

然而，儘管預防保健有所改善，但城市人口對美觀的期望不斷提高，對牙齒修復的需求也持續成長，促使牙齒修復手術數量持續增加。

缺乏保險保障

與許多新興市場不同，印度的公共醫療保險不涵蓋牙科生醫材料手術，患者必須自費支付植體和膜植入的全部費用。

這種經濟負擔限制了高成本異質骨移植和同種移植的應用，尤其是在主要城市中心以外的地區。因此，價格敏感的合成膜移植仍然是大多數私人診所的首選。

對疾病傳播的擔憂

文化和職業因素對人類和動物性疾病傳播的擔憂持續影響臨床醫生的偏好，儘管無菌和安全標準已經進步，但人們對風險的認知仍然存在，尤其是在較小的城市。

感染疾病和組織獲取問題的報告會迅速降低臨床醫生的信心，並可能迫使暫時轉向合成或自體移植。

基礎設施和培訓方面的差距

儘管牙科教育取得了顯著進步，但印度各地獲得再生醫學培訓和專用設備的機會仍然不均衡。小型診所可能缺乏進行高階移植和膜移植手術所需的工具和信心。

這種差異導致了區域市場失衡，孟買、德里和班加羅爾等大城市佔了DBGS消費的大部分。

目標市場和數據範圍

  • 量化指標：市場規模、市佔率、預測、成長率、銷售量、平均售價。
  • 定性內容：成長趨勢、市場限制、主要競爭對手的競爭分析和 SWOT 分析、併購、公司簡介、產品系列、顛覆性技術、影響手術需求的疾病概述。
  • 時段：基準年為 2024 年，預測至 2031 年，歷史資料為 2021 年至 2023 年。
  • 資料來源：對行業領導者的直接訪談、政府和監管資料、醫院和私人診所資訊來源、進出口資料庫、iData Research 的專有醫療技術資料集。
  • 方法說明：市場收入以單位 x 平均售價 (ASP) 為模型，並透過手術和臨床利用數據檢驗。

分析的醫療機構包括私人牙科診所、綜合醫院和學術機構。

目標市場及區隔

牙科移植骨替代物（DBGS）

  • 依類型：礦化同種異體移植、脫礦骨基質（DBM）同種異體移植、異質骨移植和合成移植。

牙科屏障膜

  • 依類型：可吸收型、不可吸收型
  • 依材料分類：同種異體移植、異質骨移植、複合材料。

抗菌牙周治療

含有局部應用的抗菌劑，用於控制感染和促進牙周疾病的癒合。

牙科軟組織傷口護理

  • 依類型：塞子、膠帶、泡棉。

僅對單元層面的區隔市場進行分析。

每個子類別包括市場價值、銷售、平均售價和預期成長率。

競爭分析

2024年，印度牙科生醫材料市場由蓋斯特利希製藥公司(Geistlich Pharma AG)主導。該公司旗艦產品Bio-Oss®異種移植材料被公認為骨再生領域的黃金標準。蓋斯特利希的配套產品Bio-Gide®膜產品線進一步鞏固了其在可吸收膜領域的領先地位。

儘管經濟壓力導致一些臨床醫生尋求成本更低的替代方案，但蓋斯特利希憑藉其持續的臨床教育計畫和在學術機構中的良好聲譽，仍然保持著領先地位。

Halma plc憑藉在合成DBGS領域的卓越表現排名第二。透過其專業子公司，Halma plc有效地推廣了價格親民的合成植體材料，滿足了印度注重性價比的市場需求。自2018年與ZimVie Dental簽訂獨家經銷協議以來，Halma plc進一步拓展了其在植入專家中的影響力，並提升了其產品的信譽度。

士卓曼集團對合成材料和雙相材料的策略重點在2024年佔了顯著的市場佔有率。該公司研發的骨陶瓷®（Bone Ceramic®）－一種由羥基磷灰石（HA）和BETA-磷酸三鈣（B-TCP）組成的複合材料－被推廣為士卓曼植入系統的再生補充資料。這種整合使臨床醫生能夠利用相容的再生解決方案簡化植入設計流程。

士卓曼的 Neodent® 品牌定位為經濟實惠的植入系列，同時提高了公司 DBGS 和膜產品的知名度和交叉銷售機會。

整體而言，競爭格局瞬息萬變，全球領導企業與本地經銷商和新興的印度製造商競爭。高成長環境鼓勵夥伴關係、擴大分銷管道和實現產品組合多元化。

技術與實務趨勢

  • 轉向使用屏障膜：牙科膜曾經被認為是可有可無的，但現在被認為是獲得可預測的 GBR 結果的必要條件。
  • 可吸收膜的興起：膠原蛋白基可吸收膜因其使用方便、患者舒適，正成為市場上主流的新產品。
  • 最佳化合成材料：製造商不斷改進合成移植物孔隙率、吸收率和生物相容性，以模擬天然骨再生。
  • 綜合培訓：人工植牙課程現在包含植骨和膜模組，確保從業人員在其職業生涯早期就能學習循證再生通訊協定。
  • 捆綁式產品：植入製造商正日益整合其再生產品組合，以提供包含移植片和膜的承包手術套件。
  • 都市區採用集中度：高階再生製程集中在一線城市，而對價格敏感的合成材料正在二、三線市場擴張。

綜合來看，這些趨勢顯示印度的牙科生醫材料市場正從成本主導轉變為臨床主導型。

地區

本期聚焦印度。

它包含 96 頁詳細的說明、表格和圖表。

為什麼要選擇這份報告？

印度牙科生醫材料市場成長最快的機會有哪些？

合成材料和異種移植材料在臨床應用上如何競爭？

在印度，屏障膜產品是植入主導市場中成長最快的市場。

定價、教育和銷售合作關係如何影響採用率。

文化因素與公共報銷缺口如何影響產品需求？

哪些公司在市佔率方面處於領先地位？到 2031 年，它們將如何定位自身以實現成長？

供應商如何將植入和生醫材料捆綁銷售，以最大限度地擴大市場佔有率？

哪些風險可能會限制未來的成長？企業如何透過臨床培訓和溝通來降低這些風險？

iData Research 的「印度牙科骨移植片和其他生醫材料市場報告」透過基於程式的建模、定價數據和競爭佔有率分析來回答這些問題。

在世界成長最快的牙科市場之一中，量化需求，規劃新產品發布，並對標您的策略。

目錄

圖表清單

圖表列表

調查方法

全球關稅的影響

印度牙科移植骨替代物及其他生醫材料市場

  • 摘要整理
    • 印度牙科移植骨替代物及其他生醫材料市場概覽
    • 競爭分析
    • 市場趨勢
    • 流程分段
    • 市場區隔
  • 介紹
    • 牙科骨移植替代物
    • 牙科屏障膜
    • 局部抗菌牙周治療
  • 手術次數
    • 齒槽骨移植手術
  • 計數分析
    • 依手術類型分類的牙科骨移植替代材料銷售情況
    • 牙科屏障膜單元（依尺寸）
  • 外匯
  • 市場概覽
  • 市場分析與預測
    • 牙科骨移植替代物市場
    • 牙科屏障膜市場
    • 抗菌牙周病治療市場
    • 牙科軟組織創傷護理市場
  • 推動和阻礙因素
  • 競爭市佔率分析
    • 牙科骨移植替代材料市場競爭格局分析
    • 牙科屏障膜市場競爭格局及市場佔有率分析
    • 抗菌牙周治療市場競爭市佔率分析

簡稱

Product Code: iDATA_INDBGS25_MS

The Indian dental bone graft substitute (DBGS) and other biomaterials market was valued at over $56 million in 2024. It is projected to grow, reaching nearly $151 million by 2031.

This report covers dental bone graft substitutes, dental barrier membranes, local antimicrobial periodontal treatments, and dental soft tissue wound care-collectively referred to as the dental biomaterials market. It provides comprehensive analysis across unit sales, average selling prices (ASPs), market size, growth rates, and company shares, and includes forecasts through 2031 and historical data back to 2021.

India's market is among the fastest growing globally due to expanding dental implant adoption, broader clinician training, and rising consumer awareness of regenerative procedures. The surge in dental tourism and private clinic investment is further boosting demand for advanced biomaterials, particularly synthetic and xenograft DBGS products and dental barrier membranes.

Market Overview

The Indian dental biomaterials market is in a strong expansion phase, supported by demographic and economic trends. A growing middle class, increased aesthetic awareness, and greater access to dental implant procedures are driving the uptake of regenerative dental products.

Historically, India's DBGS market has been dominated by synthetic materials due to cost advantages and availability. However, the xenograft segment has expanded steadily in recent years, gaining clinician confidence through improved sterilization, clinical outcomes, and branding from established global manufacturers.

An important shift underway in India is the rising acceptance and adoption of dental barrier membranes. While these products have historically lagged in penetration compared to DBGS materials, they are now being recognized as an essential component of guided bone regeneration (GBR) and guided tissue regeneration (GTR) procedures. Educational initiatives and company-driven workshops are accelerating the uptake of these materials, particularly resorbable collagen membranes.

The market's structure reflects a mix of global leaders such as Geistlich, Straumann Group, and Halma, alongside domestic distributors and regional players. Local partnerships and distribution alliances are critical due to India's fragmented dental infrastructure and procurement channels.

Overall, growth is being driven by a combination of rising implant procedure volumes, growing patient awareness, and strong marketing by international and domestic suppliers, positioning India as one of the most promising dental biomaterials markets in the Asia-Pacific region.

Market Drivers

Growth of Dental Implant Procedures

Dental bone grafting is integral to implantology, supporting bone volume restoration before or during implant placement. As implant adoption accelerates in India's private dental sector, the demand for DBGS materials continues to expand.

While not every implant requires a bone graft, a significant proportion of cases-especially in posterior maxilla and mandible regions-benefit from grafting to ensure long-term stability. This structural link between implant placement and bone grafting ensures that DBGS demand rises alongside implant procedure growth.

Growing Consumer Awareness

Public awareness of dental implantology and regenerative procedures has increased markedly. Patients are becoming more informed about treatment options through digital channels and educational campaigns sponsored by implant and biomaterial manufacturers.

This expanding knowledge base has elevated both clinical acceptance and consumer trust, driving steady procedural adoption of DBGS and barrier membrane products.

Bundling and Portfolio Expansion

Leading dental companies are leveraging product bundling strategies to cross-sell DBGS materials, membranes, and implant systems. Many global firms-including Geistlich, Straumann, and Halma-offer regenerative materials alongside implants, encouraging clinicians to source complementary products from a single supplier.

These partnerships simplify logistics for dental clinics and enhance procedural consistency. For example, Geistlich's Bio-Gide(R) membranes are commonly used with its Bio-Oss(R) xenografts, while Straumann promotes its Bone Ceramic(R) material as part of its implant regeneration package.

Such integration of implants and biomaterials portfolios enhances sales synergy and drives higher overall market penetration.

Private Healthcare Growth and Dental Tourism

India's private healthcare expansion and booming dental tourism sector have amplified investment in advanced dental technologies. Clinics catering to international and affluent domestic patients increasingly adopt premium DBGS and membrane materials to ensure predictable aesthetic outcomes.

With competitive pricing and growing international reputation, India has become a favored destination for implant procedures, further bolstering demand for regenerative materials.

Market Limiters

Improvements in Oral Health

Preventive dental awareness is improving across India due to government and NGO-led oral hygiene campaigns. While this is beneficial from a public health standpoint, it may slow long-term demand for restorative and regenerative procedures.

Nevertheless, rising aesthetic expectations and tooth replacement demand among urban populations continue to sustain procedural volume growth despite better preventive care.

Lack of Insurance Coverage

Unlike in many developed markets, dental biomaterial procedures in India are not covered by public health insurance. Patients must pay the entire cost of grafting and membrane placement out of pocket.

This financial burden limits the adoption of high-cost xenograft and allograft products, particularly outside major metropolitan centers. As a result, price-sensitive synthetic grafts remain the dominant choice for most private practitioners.

Concerns About Disease Transmission

Cultural and professional apprehension about disease transmission from human or animal sources continues to influence clinician preferences. Although sterilization and safety standards have advanced, the perception of risk persists, particularly in smaller cities.

Any reports of infection or issues in tissue sourcing can quickly reduce clinician confidence, leading to temporary shifts back to synthetic or autogenous grafts.

Infrastructure and Training Gaps

Despite major progress in dental education, access to regenerative training and specialized equipment remains uneven across India. Smaller clinics may lack the tools and confidence required for advanced grafting or membrane procedures.

This disparity reinforces regional market imbalances, with major cities like Mumbai, Delhi, and Bengaluru accounting for the majority of DBGS consumption.

Market Coverage and Data Scope

  • Quantitative coverage: Market size, market shares, forecasts, growth rates, units sold, and average selling prices.
  • Qualitative coverage: Growth trends, market limiters, competitive analysis and SWOT for top competitors, mergers and acquisitions, company profiles, product portfolios, disruptive technologies, and disease overviews that influence procedural demand.
  • Time frame: Base year 2024, forecasts to 2031, and historical data from 2021 to 2023.
  • Data sources: Primary interviews with industry leaders, government and regulatory data, hospital and private clinic sources, import/export databases, and iData Research's proprietary MedTech dataset.
  • Method note: Market revenue is modeled from units X ASP, validated with procedural and clinical utilization data.

Care settings analyzed include private dental clinics, multispecialty hospitals, and academic institutions.

Markets Covered and Segmentation

Dental Bone Graft Substitutes (DBGS)

  • By type: Mineralized allografts, demineralized bone matrix (DBM) allografts, xenografts, synthetics.

Dental Barrier Membranes

  • By type: Resorbable, non-resorbable.
  • By material: Allograft, xenograft, synthetic.

Antimicrobial Periodontal Treatment

Includes locally applied antimicrobial agents used to control infection and promote periodontal healing.

Dental Soft Tissue Wound Care

  • By type: Plug, tape, foam.

Segment analyzed at the unit level only.

Each subcategory includes market values, units sold, ASPs, and forecast growth rates.

Competitive Analysis

Geistlich Pharma AG led the Indian dental biomaterials market in 2024. Its flagship xenograft product, Bio-Oss(R), is widely regarded as the gold standard for bone regeneration. Geistlich's complementary Bio-Gide(R) membrane line further reinforces its leadership by dominating the resorbable membrane segment.

Despite broader economic pressures that encouraged some clinicians to explore lower-cost alternatives, Geistlich retained its top position through consistent clinical education programs and a strong reputation among academic institutions.

Halma plc ranked second, driven by its success in the synthetic DBGS segment. Through its specialized subsidiaries, Halma has effectively promoted affordable synthetic graft materials that appeal to India's value-oriented market. Its exclusive distribution agreement with ZimVie Dental since 2018 strengthened its reach and product credibility among implant specialists.

Straumann Group held a notable market share in 2024, with a strategic focus on synthetic and biphasic materials. Its Bone Ceramic(R)-a combination of hydroxyapatite (HA) and beta-tricalcium phosphate (B-TCP)-was promoted as a regenerative complement to Straumann's implant systems. This integration allowed clinicians to streamline implant planning with compatible regenerative solutions.

Straumann's Neodent(R) brand, positioned as a cost-effective implant line, also enhanced visibility and cross-selling opportunities for the company's DBGS and membrane products.

Overall, the competitive environment is dynamic, with global leaders competing alongside local distributors and emerging Indian manufacturers. The high-growth environment encourages partnerships, distribution expansion, and portfolio diversification.

Technology and Practice Trends

  • Shift toward barrier membrane use: Dental membranes, once considered optional, are now viewed as essential for predictable GBR outcomes.
  • Resorbable membranes gaining traction: Collagen-based resorbable membranes dominate new product introductions due to handling simplicity and patient comfort.
  • Synthetic material optimization: Manufacturers continue improving porosity, resorption rates, and biocompatibility of synthetic grafts to emulate natural bone regeneration.
  • Training integration: Dental implant courses now incorporate grafting and membrane modules, ensuring practitioners learn evidence-based regenerative protocols early in their careers.
  • Bundled offerings: Implant manufacturers increasingly integrate regenerative portfolios, offering turnkey surgical kits that include grafts and membranes.
  • Urban concentration of adoption: High-end regenerative procedures are concentrated in Tier 1 cities, while price-sensitive synthetic materials are expanding in Tier 2 and 3 markets.

Collectively, these trends underline India's transition from a cost-driven to a clinically driven dental biomaterials market.

Geography

This edition focuses on India.

96 pages of in-depth narrative, tables, and charts.

Why This Report

Where is the fastest-growing opportunity within India's dental biomaterials market?

How are synthetic and xenograft materials competing in clinical adoption?

Which barrier membrane products are expanding most rapidly in India's implant-driven market?

What is the impact of pricing, education, and distribution partnerships on adoption rates?

How do cultural factors and public reimbursement gaps shape product demand?

Which companies are leading in market share, and how are they positioning for growth through 2031?

How can suppliers bundle implants and biomaterials to maximize market presence?

What risks may limit future growth, and how can companies mitigate them through clinical training and communication?

The India Dental Bone Graft Substitute and Other Biomaterials Market Report from iData Research answers these questions with procedure-based modeling, pricing data, and competitive share analysis.

Use it to quantify demand, plan new product entries, and benchmark strategies in one of the world's fastest-growing dental markets.

TABLE OF CONTENT

Table Of Contents

List Of Figures

List Of Charts

Research Methodology

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems And Perform Secondary Research
  • Step 3: Preparation For Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast And Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review And Market Release
  • Step 9: Customer Feedback And Market Monitoring

Impact Of Global Tariffs

India Dental Bone Graft Substitute and Other Biomaterials Market

  • 7.1 Executive Summary
    • 7.1.1 India Dental Bone Graft Substitute and Other Biomaterials Market Overview
    • 7.1.2 Competitive Analysis
    • 7.1.3 Market Trends
    • 7.1.4 Procedure Segmentation
    • 7.1.5 Market Segmentation
  • 7.2 Introduction
    • 7.2.1 Dental Bone Graft Substitutes
      • 7.2.1.1 Autografts
      • 7.2.1.2 Allografts
      • 7.2.1.2.1 Mineralized Allografts
      • 7.2.1.2.2 Demineralized Bone Matrix
      • 7.2.1.3 Xenografts
      • 7.2.1.4 Synthetics
    • 7.2.2 Dental Barrier Membranes
    • 7.2.3 Local Antimicrobial Periodontal Treatment
  • 7.3 Procedure Numbers
    • 7.3.1 Dental Bone Grafting Procedures
  • 7.4 Unit Analysis
    • 7.4.1 Dental Bone Graft Substitute Units Sold by Procedure Type
    • 7.4.2 Dental Barrier Membrane Units Sold by Size
      • 7.4.2.1 Resorbable Dental Barrier Membrane Units Sold by Size
      • 7.4.2.2 Non-Resorbable Dental Barrier Membrane Units Sold by Size
  • 7.5 Currency Exchange Rate
  • 7.6 Market Overview
  • 7.7 Market Analysis and Forecast
    • 7.7.1 Dental Bone Graft Substitute Market
      • 7.7.1.1 Allograft Market
      • 7.7.1.1.1 Mineralized Allograft Market
      • 7.7.1.1.2 Demineralized Bone Matrix Allograft Market
      • 7.7.1.2 Xenograft Market
      • 7.7.1.3 Synthetic Market
    • 7.7.2 Dental Barrier Membrane Market
      • 7.7.2.1 Dental Barrier Membrane Market by Segment
      • 7.7.2.1.1 Allograft Dental Barrier Membrane Market
      • 7.7.2.1.2 Xenograft Dental Barrier Membrane Market
      • 7.7.2.1.3 Synthetic Dental Barrier Membrane Market
      • 7.7.2.2 Dental Barrier Membrane Market by Material
      • 7.7.2.2.1 Resorbable Dental Barrier Membrane Market
      • 7.7.2.2.2 Non-Resorbable Dental Barrier Membrane Market
    • 7.7.3 Antimicrobial Periodontal Treatment Market
    • 7.7.4 Dental Soft Tissue Wound Care Market
      • 7.7.4.1 Dental Wound Care Plugs Market
      • 7.7.4.2 Dental Wound Care Tape Market
      • 7.7.4.3 Dental Wound Care Foam Market
  • 7.8 Drivers and Limiters
    • 7.8.1 Market Drivers
    • 7.8.2 Market Limiters
  • 7.9 Competitive Market Share Analysis
    • 7.9.1 Dental Bone Graft Substitute Market Competitive Market Share Analysis
    • 7.9.2 Dental Barrier Membrane Market Competitive Market Share Analysis
    • 7.9.3 Antimicrobial Periodontal Treatment Market Competitive Market Share Analysis

Abbreviations

LIST OF CHARTS

  • Chart 7-1: Dental Bone Graft Substitute and Other Biomaterials by Segment, India, 2024
  • Chart 7-2: Dental Bone Graft Substitute and Other Biomaterials Market Overview, India, 2024 & 2031
  • Chart 7-3: Dental Bone Grafting Procedures by Segment, India, 2021 - 2031
  • Chart 7-4: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031
  • Chart 7-5: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, India, 2024

LIST OF FIGURES

  • Figure 7-1: Dental Bone Graft Substitute and Other Biomaterials Market Share Ranking by Segment, India, 2024
  • Figure 7-2: Factors Impacting the Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India
  • Figure 7-3: Dental Bone Graft Substitute and Other Biomaterials Procedure Segmentation, India
  • Figure 7-4: Dental Bone Graft Substitute and Other Biomaterials Market Segmentation, India
  • Figure 7-5: Dental Bone Grafting Procedures and Penetration Rates by Segment, India, 2021 - 2031
  • Figure 7-6: Dental Bone Graft Procedure Numbers and Volume Usage by Application, India, 2021 - 2031 (1 of 2)
  • Figure 7-7: Dental Bone Graft Procedure Numbers and Volume Usage by Application, India, 2021 - 2031 (2 of 2)
  • Figure 7-8: Dental Bone Graft Units Sold by Procedure, India, 2021 - 2031
  • Figure 7-9: Resorbable Dental Barrier Membrane Units Sold by Size, India, 2021 - 2031
  • Figure 7-10: Non-Resorbable Dental Barrier Membrane Units Sold by Size, India, 2021 - 2031
  • Figure 7-11: Currency Exchange Rate, 2024
  • Figure 7-12: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-13: Dental Bone Graft Substitute and Other Biomaterials Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-14: Total Dental Bone Graft Substitute Market, India, 2021 - 2031
  • Figure 7-15: Dental Bone Graft Substitute Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-16: Dental Bone Graft Substitute Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-17: Allograft Market by Material, India, 2021 - 2031 (US$M)
  • Figure 7-18: Allograft Market by Material, India, 2021 - 2031 (IN₹M)
  • Figure 7-19: Total Allograft Market, India, 2021 - 2031
  • Figure 7-20: Mineralized Allograft Market, India, 2021 - 2031
  • Figure 7-21: Demineralized Bone Matrix Allograft Market, India, 2021 - 2031
  • Figure 7-22: Xenograft Market, India, 2021 - 2031
  • Figure 7-23: Synthetic Market, India, 2021 - 2031
  • Figure 7-24: Total Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-25: Dental Barrier Membrane Market by Segment, India, 2021 - 2031 (US$M)
  • Figure 7-26: Dental Barrier Membrane Market by Segment, India, 2021 - 2031 (IN₹M)
  • Figure 7-27: Allograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-28: Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-29: Bovine Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-30: Porcine Xenograft Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-31: Synthetic Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-32: Dental Barrier Membrane Market by Material, India, 2021 - 2031 (US$M)
  • Figure 7-33: Dental Barrier Membrane Market by Material, India, 2021 - 2031 (IN₹M)
  • Figure 7-34: Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-35: Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-36: Non-Reinforced Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-37: Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market, India, 2021 - 2031
  • Figure 7-38: Total Antimicrobial Periodontal Treatment Market, India, 2021 - 2031
  • Figure 7-39: Dental Wound Care Market by Type, India, 2021 - 2031 (US$M)
  • Figure 7-40: Dental Wound Care Market by Type, India, 2021 - 2031 (IN₹M)
  • Figure 7-41: Dental Soft Tissue Wound Care Market, India 2021 - 2031
  • Figure 7-42: Dental Wound Care Plugs Market, India, 2021 - 2031
  • Figure 7-43: Dental Wound Care Tape Market, India, 2021 - 2031
  • Figure 7-44: Dental Wound Care Foam Market, India, 2021 - 2031
  • Figure 7-45: Leading Competitors, Dental Bone Graft Substitute and Other Biomaterials Market, India, 2024
  • Figure 7-46: Leading Competitors, Dental Bone Graft Substitute Market, India, 2024
  • Figure 7-47: Leading Competitors, Dental Barrier Membrane Market, India, 2024
  • Figure 7-48: Leading Competitors, Antimicrobial Periodontal Treatment Market, India, 2024